Efficacy and safety of strontium ranelate/vitamin D3 combination on vitamin D insufficiency in the treatment of osteoporotic patient

Phase 3

Completed

• Conditions: Osteoporosis, vitamin D insufficiency; Nutritional, Metabolic, Endocrine; Vitamin D insufficiency

• Registration Number: ISRCTN59279012
• Lead Sponsor: Institut de Recherches Internationales Servier (France)

Brief Summary

2014 results in: https://www.ncbi.nlm.nih.gov/pubmed/24322182

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-05-28
• Study Completion: 2011-07-22
• Last Update Posted: 21 May 2018

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

1. Osteoporotic men and osteoporotic post-menopausal women
2. Age superior or equal 50 years, either sex
3. Caucasian
4. 25-OH vitamin D3 serum concentration greater than 22.5 nmol/

Exclusion Criteria

1. Progressive major illness, uncontrolled active disease, skeletal disease
2. History or increased risk of deep venous thrombosis or pulmonary embolism
3. History of intolerance, allergy or severe hypersensitivity with study drugs

Study & Design

• Study Type: Interventional
• Study Design: Not specified